A randomized clinical trial of continuous flow nitrous oxide and nalbuphine infusion for sedation of patients during radiofrequency atrial flutter ablation

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 4, 2006, Pages 351-357

  Laurent, Gabriel ^a,b   Bertaux, Géraldine ^a   Martel, Alexandra ^a   Fraison, Michel ^a   Fromentin, Stéphane ^a   Gonzalez, Stéphanie ^a   Pierre, François Saint ^a   Wolf, Jean Eric ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Atrial flutter ablation; Discomfort; Inhaled nitrous oxide

Indexed keywords

NALBUPHINE; NITROUS OXIDE PLUS OXYGEN;

ADULT; AGED; ANESTHESIA COMPLICATION; ANXIETY; ARTICLE; ASPIRATION; CATHETER; CATHETER ABLATION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HALLUCINATION; HEART ATRIUM FLUTTER; HUMAN; HYPOTENSION; INHALATION ANESTHESIA; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SEDATION; SIDE EFFECT; TRANQUILIZING ACTIVITY; TRICUSPID VALVE; VISUAL ANALOG SCALE; VOMITING;

ADMINISTRATION, INHALATION; ANALGESICS, OPIOID; ANESTHETICS, INHALATION; ANXIETY; ATRIAL FLUTTER; CATHETER ABLATION; CONSCIOUS SEDATION; DRUG COMBINATIONS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NALBUPHINE; NITROUS OXIDE; PAIN; TREATMENT OUTCOME;

EID: 33645725218     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00352.x     Document Type: Article

References (29)

1. Cosio FG Lopez-Gil M Goicolea A Arribas F Barroso JL. Radiofrequency ablation of the inferior vena cava-tricuspid isthmus in common atrial flutter. Am J Cardiol 1993 71 7055 7059.
2. Kirkorian G Moncada E Chevalier P et al. Radiofrequency ablation of atrial flutter. Efficacy of an anatomically guided approach. Circulation 1994 90 2804 2814.
3. Jais P Shah DC Haissaguerre M et al. Prospective randomized comparison of irrigated-tip versus conventional-tip catheters for ablation of common flutter. Circulation 2000 101 772 776.
4. Chen J de Chillou C Basiouny T et al. Cavotricuspid isthmus mapping to access bidirectional block during common atrial flutter radiofrequency ablation. Circulation 1999 100 2507 2513.
5. Hew E Foster K Gordon R Hew-Sang E. A comparison of Nalbuphine and meperidine in treatment of postoperative pain. Can J Anaesth 1987 34 462 465.
6. Miller RR. Evaluation of Nalbuphine hydrochloride. Am J Hosp Pharm 1980 37 942 949.
7. Zelis R Mansour EJ Capone RJ Mason DT. The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects. J Clin Invest 1974 54 1247 1258.
8. O'Leary U Puglia C Friehling TD Kowey PR. Nitrous oxide anesthesia in patients with ischemic chest discomfort: Effect on beta-endorphins. J Clin Pharmacol 1987 27 957 961.
9. Kaplan RM Heller MB McPherson J Paris PM. An evaluation of nitrous oxide analgesia during transcutaneous pacing. Prehospital Disaster Med 1990 5 145 149.
10. Vlaeyen JW Timmermans C Rodriguez LM et al. Catastrophic thinking about pain increases discomfort during internal atrial cardioversion. J Psychosom Res 2004 56 139 144.
11. Stewart RD. Nitrous oxide sedation/analgesia in emergency medicine. Ann Emerg Med 1985 14 139 148.
12. Gillman MA. Possible mechanisms of action of nitrous oxide at the opioid receptor. Med Hypotheses 1984 15 109 114.
13. Tada H Oral H Sticherling C et al. Double potentials along the ablation line as a guide to radiofrequency ablation of typical atrial flutter. J Am Coll Cardiol 2001 38 750 755.
14. Shah D Haïssaguerre M Takahashi A Jaïs P Hocini M Clémenty J. Differential pacing for distinguishing block from persistent conduction through an ablation line. Circulation 2000 102 1517 1522.
15. Franssen C Hans P Brichant JF Noirot D Lamy M. Comparison between alprazolam and hydroxyzine for oral premedication. Can J Anesth 1993 40 13 17.
16. Guth A Hennen B Kramer T Stoll HP Bohm M. Plasma lidocaine concentrations after local anesthesia of the groin for cardiac catheterization. Catheter Cardiovasc Interv 2002 57 342 345.
17. Dorsch J Dorsch S. Understanding Anesthesia Equipment. 3rd ed. Baltimore MD Williams & Wilkins 1994 pp. 167 189.
18. Timmermans C Ayers GM Crijns HJ Rodriguez LM. Randomized study comparing radiofrequency ablation with cryoablation for the treatment of atrial flutter with emphasis on pain perception. Circulation 2003 107 1250 1252.
19. Lowe MD Meara M Mason J Grace AA Murgatroyd FD. Catheter cryoablation of supraventricular arrhythmias: A painless alternative to radiofrequency energy. Pacing Clin Electrophysiol 2003 26 1 Pt 2 500 503.
20. Zacny JP Cho AM Coalson DW et al. Differential acute tolerance development to effects of nitrous oxide in humans. Neurosci Lett 1996 209 73 76.
21. Ramsay DS Leroux BG Rothen M Prall CW Fiset LO Woods SC. Nitrous oxide analgesia in humans: Acute and chronic tolerance. Pain 2005 114 19 28.
22. Fosburg MT Crone RK. Nitrous oxide analgesia for refractory pain in the terminally ill. JAMA 1983 250 511 513.
23. Ujhelyi M Hoyt RH Burns K Fishman RS Musley S Silverman MH. Nitrous oxide sedation reduces discomfort caused by atrial defibrillation shocks. Pacing Clin Electrophysiol 2004 27 485 491.
24. Lichtor JL Lane BS Zimmerman MB. Residual sleepiness after N2O sedation: A randomized control trial. BMC Anesthesiol 2004 4 5.
25. Parbrook GE. Therapeutic uses of nitrous oxide: A review. Br J Anaesth 1968 40 365 372.
26. 2O. Pain 1984 19 339 351.
27. Gear RW Miaskowski C Gordon NC Paul SM Heller PH Levine JD. The kappa opioid Nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain 1999 83 339 345.
28. Jaillon P Gardin ME Lecocq B et al. Pharmacokinetics of Nalbuphine in infants, young healthy volunteers, and elderly patients. Clin Pharmacol Ther 1989 46 226 233.
29. Dunlosky J Domoto PK Wang ML et al. Inhalation of 30% nitrous oxide impairs people's learning without impairing people's judgments of what will be remembered. Exp Clin Psychopharmacol 1998 6 77 86.